Skip to main content

Samuelson Doug

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Samuelson Doug as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

KAPA Kairos Pharma, LTD.

Chief Financial Officer1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 25, 2024 (view filing)Nov 223 daysSamuelson DougChief Financial OfficerPPurchase+2.50K$1.50+$3.75K+4.3%60.8K after

GNLX GENELUX Corp

Vice President, Finance1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 22, 2023 (view filing)Aug 184 daysSamuelson DougChief Financial OfficerSSale−1.30K$23.73−$30.8K−36.0%2.30K after